Skip to main content

Lyra Therapeutics, Inc.

LYRADelisted Apr 20, 2026
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001327273

Lyra Therapeutics, Inc. was delisted on Apr 20, 2026; its insiders filed their last Form 4 on May 15, 2026; 23 institutions reported holding it in 13F filings for Q4 2025, worth $747.3K in total; no superinvestor held it.

13F holders, Q4 2021

Institutional positions in Lyra Therapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
34
−2 vs. Q3 2021
Shares held
5.13M
−432.0K (−7.8%) vs. Q3 2021
Total value
$22.4M
−$28.4M (−55.9%) vs. Q3 2021
New holders
6
7 more added
Sold out
8
11 more reduced

1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting LYRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2021: 34 institutions
Q1 2021: 50 institutionsQ2 2021: 46 institutionsQ3 2021: 37 institutionsQ4 2021: 34 institutionsQ1 2022: 28 institutionsQ2 2022: 38 institutionsQ3 2022: 38 institutionsQ4 2022: 37 institutionsQ1 2023: 31 institutionsQ2 2023: 39 institutionsQ3 2023: 45 institutionsQ4 2023: 60 institutionsQ1 2024: 79 institutionsQ2 2024: 51 institutionsQ3 2024: 62 institutionsQ4 2024: 54 institutionsQ1 2025: 57 institutionsQ2 2025: 30 institutionsQ3 2025: 26 institutionsQ4 2025: 23 institutionsQ1 2026: 1 institutionQ2 2026: 0 institutions
Value heldQ4 2021: $22.4M
Q1 2021: $87.6MQ2 2021: $56.0MQ3 2021: $60.8MQ4 2021: $22.4MQ1 2022: $20.2MQ2 2022: $108.9MQ3 2022: $96.0MQ4 2022: $59.9MQ1 2023: $38.1MQ2 2023: $138.4MQ3 2023: $124.8MQ4 2023: $222.0MQ1 2024: $283.4MQ2 2024: $9.06MQ3 2024: $8.36MQ4 2024: $5.54MQ1 2025: $3.23MQ2 2025: $4.42MQ3 2025: $2.93MQ4 2025: $747.3KQ1 2026: $51.1KQ2 2026: $0
Institutions holding LYRA and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20261$51.1K
Q4 202523$747.3K
Q3 202526$2.93M
Q2 202530$4.42M
Q1 202557$3.23M
Q4 202454$5.54M
Q3 202462$8.36M
Q2 202451$9.06M
Q1 202479$283.4M
Q4 202360$222.0M
Q3 202345$124.8M
Q2 202339$138.4M
Q1 202331$38.1M
Q4 202237$59.9M
Q3 202238$96.0M
Q2 202238$108.9M
Q1 202228$20.2M
Q4 202134$22.4M
Q3 202137$60.8M
Q2 202146$56.0M
Q1 202150$87.6M

Institutions, Q4 2021

Shares, value and share of portfolio for each institution holding Lyra Therapeutics, Inc.; share changes are against Q3 2021.

Institutions holding LYRA in Q4 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Perceptive Advisors LLC3,222,560$14.1M0.22%00.0%Unchanged
Pura Vida Investments, LLC517,244$2.25M0.24%−16,173−3.0%Reduced
Ikarian Capital, LLC394,536$1.72M0.49%−8,914−2.2%Reduced
Vanguard Group Inc218,753$954.0K0.00%−1,276−0.6%Reduced
Millennium Management LLC152,934$667.0K0.00%+34,776+29.4%Added
Bank of America Corp83,840$366.0K0.00%−26,671−24.1%Reduced
Pentwater Capital Management LP71,313$311.0K0.00%+39,299+122.8%Added
Bridgeway Capital Management, LLC66,900$292.0K0.01%−2,000−2.9%Reduced
Clearline Capital LP64,862$283.0K0.04%+64,862New
Two Sigma Advisers, LP56,700$247.0K0.00%−1,300−2.2%Reduced
Renaissance Technologies LLC52,000$227.0K0.00%+52,000New
Ensign Peak Advisors, Inc39,167$171.0K0.00%00.0%Unchanged
Boothbay Fund Management, LLC38,516$168.0K0.01%−684−1.7%Reduced
Geode Capital Management, LLC36,018$157.0K0.00%00.0%Unchanged
BlackRock Inc.18,273$80.0K0.00%+455+2.6%Added
Two Sigma Investments, LP17,731$77.0K0.00%+4,347+32.5%Added
Citadel Advisors LLC13,252$58.0K0.00%+13,252New
Virtu Financial LLC13,127$57.0K0.01%+13,127New
Susquehanna International Group, LLP11,200$49.0K0.00%−4,695−29.5%Reduced
Tower Research Capital LLC (TRC)10,655$47.0K0.00%+6,420+151.6%Added
Soleus Capital Management, L.P.10,000$44.0K0.01%−205,576−95.4%Reduced
Morgan Stanley9,431$41.0K0.00%−20,732−68.7%Reduced
Close Asset Management Ltd7,000$30.0K0.00%00.0%Unchanged
UBS Group AG4,070$18.0K0.00%+4,052+22,511.1%Added
Advisor Group Holdings, Inc.1,234$5.00K0.00%00.0%Unchanged
JPMorgan Chase & Co849$4.00K0.00%+815+2,397.1%Added
US Bancorp500$2.00K0.00%00.0%Unchanged
Wells Fargo & Company537$2.00K0.00%00.0%Unchanged
Laurel Wealth Advisors LLC500$2.00K0.00%00.0%Unchanged
CoreCap Advisors, LLC125$1.00K0.00%+125New
Koshinski Asset Management, Inc.200$8720.00%00.0%Unchanged
TD Waterhouse Canada Inc.200$8700.00%+200New
Royal Bank of Canada77$00.00%−210−73.2%Reduced
Investors Research Corp15$00.00%00.0%Unchanged
ArrowMark Colorado Holdings LLC0$00.00%−139,187−100.0%Sold out
Parian Global Management LP0$00.00%−121,300−100.0%Sold out
Deutsche Bank AG0$00.00%−76,352−100.0%Sold out
Ergoteles LLC0$00.00%−16,273−100.0%Sold out
Marshall Wace, LLP0$00.00%−12,457−100.0%Sold out
Trexquant Investment LP0$00.00%−11,085−100.0%Sold out
Cardinal Capital Management, Inc.0$00.00%−650−100.0%Sold out
Harbour Investments, Inc.0$00.00%−175−100.0%Sold out
Polaris Venture Management Co. V, L.L.C.––––Not filed